Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 234

1.

Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility.

D'Alessandro R, Refolo MG, Iacovazzi PA, Pesole PL, Messa C, Carr BI.

Cancers (Basel). 2019 Jun 7;11(6). pii: E787. doi: 10.3390/cancers11060787.

2.

One-Stage Augmentation Mastopexy: A Retrospective Ten-Year Review of 2,183 Consecutive Procedures.

Messa CA, Messa CA.

Aesthet Surg J. 2019 May 11. pii: sjz143. doi: 10.1093/asj/sjz143. [Epub ahead of print]

PMID:
31077272
3.

Ultrasonic debridement management of lower extremity wounds: retrospective analysis of clinical outcomes and cost.

Messa CA 4th, Chatman BC, Rhemtulla IA, Broach RB, Mauch JT, D'Angelantonio AM 3rd, Fischer JP.

J Wound Care. 2019 May 1;28(Sup5):S30-S40. doi: 10.12968/jowc.2019.28.Sup5.S30.

PMID:
31067172
4.

Adherence to oral pharmacological treatment in cancer patients: Systematic review.

Claros MP, Messa CVM, García-Perdomo HA.

Oncol Rev. 2019 Apr 16;13(1):402. doi: 10.4081/oncol.2019.402. eCollection 2019 Jan 14.

5.

Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer.

De Bernardi E, Buda A, Guerra L, Vicini D, Elisei F, Landoni C, Fruscio R, Messa C, Crivellaro C.

EJNMMI Res. 2018 Aug 22;8(1):86. doi: 10.1186/s13550-018-0441-1.

6.

Cannabinoid Receptor-1 Up-regulation in Azoxymethane (AOM)-treated Mice After Dietary Treatment with Quercetin.

Tutino V, DE Nunzio V, Tafaro A, Bianco G, Gigante I, Scavo MP, D'Alessandro R, Refolo MG, Messa C, Caruso MG, Notarnicola M.

Anticancer Res. 2018 Aug;38(8):4485-4491. doi: 10.21873/anticanres.12752.

PMID:
30061214
7.

Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells.

Refolo MG, Lippolis C, Carella N, Cavallini A, Messa C, D'Alessandro R.

Int J Mol Sci. 2018 May 19;19(5). pii: E1518. doi: 10.3390/ijms19051518.

8.

Role of Prophylactic Mesh Placement for Laparotomy and Stoma Creation.

Rhemtulla IA, Messa CA 4th, Enriquez FA, Hope WW, Fischer JP.

Surg Clin North Am. 2018 Jun;98(3):471-481. doi: 10.1016/j.suc.2018.01.003. Review.

PMID:
29754617
9.

Prophylactic mesh augmentation: Patient selection, techniques, and early outcomes.

Rhemtulla IA, Mauch JT, Broach RB, Messa CA, Fischer JP.

Am J Surg. 2018 Sep;216(3):475-480. doi: 10.1016/j.amjsurg.2018.04.008. Epub 2018 Apr 22.

PMID:
29709271
10.

Comparative Effectiveness of Retromuscular and Intraperitoneal Repair: What Is the Value of Posterior Sheath Reconstruction?

Carney MJ, Messa CA 4th, Weissler JM, Shakir S, Wes AM, Enriquez FA, Hsu JY, Roth JS, Kovach SJ, Fischer JP.

Plast Reconstr Surg. 2018 May;141(5):733e-741e. doi: 10.1097/PRS.0000000000004298.

PMID:
29697627
11.

Gender-Affirming Surgery in Persons with Gender Dysphoria.

Weissler JM, Chang BL, Carney MJ, Rengifo D, Messa CA 4th, Sarwer DB, Percec I.

Plast Reconstr Surg. 2018 Mar;141(3):388e-396e. doi: 10.1097/PRS.0000000000004123.

PMID:
29481407
12.

Strong enhancement by IGF1-R antagonists of hepatocellular carcinoma cell migration inhibition by Sorafenib and/or vitamin K1.

D'Alessandro R, Refolo MG, Lippolis C, Carella N, Messa C, Cavallini A, Carr BI.

Cell Oncol (Dordr). 2018 Jun;41(3):283-296. doi: 10.1007/s13402-018-0370-z. Epub 2018 Feb 22.

PMID:
29470830
13.

Using Crowdsourcing as a Platform to Evaluate Lay Perception of Prophylactic Mesh Placement.

Weissler JM, Carney MJ, Enriquez FA, Messa CA 4th, Broach R, Shapira MM, Barg FK, Fischer JP.

J Surg Res. 2019 May;237:78-86. doi: 10.1016/j.jss.2017.11.065. Epub 2017 Dec 29.

PMID:
29290370
14.

IGF-1R tyrosine kinase inhibitors and Vitamin K1 enhance the antitumor effects of Regorafenib in HCC cell lines.

Refolo MG, D'Alessandro R, Lippolis C, Carella N, Cavallini A, Messa C, Carr BI.

Oncotarget. 2017 Sep 30;8(61):103465-103476. doi: 10.18632/oncotarget.21403. eCollection 2017 Nov 28.

15.

High-Intensity Focused Ultrasound- and Radiation Therapy-Induced Immuno-Modulation: Comparison and Potential Opportunities.

Cirincione R, Di Maggio FM, Forte GI, Minafra L, Bravatà V, Castiglia L, Cavalieri V, Borasi G, Russo G, Lio D, Messa C, Gilardi MC, Cammarata FP.

Ultrasound Med Biol. 2017 Feb;43(2):398-411. doi: 10.1016/j.ultrasmedbio.2016.09.020. Epub 2016 Oct 22. Review.

PMID:
27780661
16.

Evaluation of erlotinib treatment response in non-small cell lung cancer using metabolic and anatomic criteria.

Stefano A, Russo G, Ippolito M, Cosentino S, Murè G, Baldari S, Sabini MG, Sardina D, Valastro LM, Bordonaro R, Messa C, Gilardi MC, Soto Parra H.

Q J Nucl Med Mol Imaging. 2016 Sep;60(3):264-73.

PMID:
27463889
17.

Does Implant Insertion with a Funnel Decrease Capsular Contracture? A Preliminary Report.

Flugstad NA, Pozner JN, Baxter RA, Creasman C, Egrari S, Martin S, Messa CA 3rd, Oliva A, Schlesinger SL, Kortesis BG.

Aesthet Surg J. 2016 May;36(5):550-6. doi: 10.1093/asj/sjv237. Epub 2015 Dec 15.

PMID:
26672104
18.

Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC.

D'Alessandro R, Messa C, Refolo MG, Carr BI.

Expert Opin Pharmacother. 2015;16(18):2773-80. doi: 10.1517/14656566.2015.1101065. Epub 2015 Oct 19. Review.

PMID:
26479083
19.

Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1.

Lippolis C, Refolo MG, D'Alessandro R, Carella N, Messa C, Cavallini A, Carr BI.

J Exp Clin Cancer Res. 2015 Sep 2;34:90. doi: 10.1186/s13046-015-0210-1.

20.

Quantification of Dynamic [18F]FDG Pet Studies in Acute Lung Injury.

Grecchi E, Veronese M, Moresco RM, Bellani G, Pesenti A, Messa C, Bertoldo A.

Mol Imaging Biol. 2016 Feb;18(1):143-52. doi: 10.1007/s11307-015-0871-3.

PMID:
26099506

Supplemental Content

Support Center